methylprednisolone has been researched along with Leukemia, Plasmacytic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kobayashi, H; Kobayashi, Y; Shimizu, S; Sugimura, H; Tamashima, S; Tanioka, F | 1 |
Fritsch, H; Höltermann, F; Klug, S | 1 |
2 other study(ies) available for methylprednisolone and Leukemia, Plasmacytic
Article | Year |
---|---|
A case of primary plasma cell leukemia with hairy-cell morphology and lambda-type Bence-Jones protein. Immunohistochemical and molecular analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Base Sequence; Bence Jones Protein; Doxorubicin; Germinal Center; Humans; Immunoglobulin Heavy Chains; Immunoglobulin lambda-Chains; Immunoglobulin Light Chains; Immunoglobulin Variable Region; Immunohistochemistry; Leukemia, Hairy Cell; Leukemia, Plasma Cell; Male; Methotrexate; Methylprednisolone; Middle Aged; Molecular Sequence Data; Vinblastine | 2003 |
[IgG-lambda-type multiple myeloma with plasma-cell pericardial effusion and terminal plasma-cell leukemia].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aortic Valve Insufficiency; Drug Therapy, Combination; Female; Humans; Immunoglobulin lambda-Chains; Leukemia, Plasma Cell; Melphalan; Methylprednisolone; Mitral Valve Stenosis; Multiple Myeloma; Pericardial Effusion; Plasma Cells | 1992 |